Ignite Creation Date:
2025-12-24 @ 3:39 PM
Ignite Modification Date:
2026-01-20 @ 2:25 AM
Study NCT ID:
NCT01741792
Status:
COMPLETED
Last Update Posted:
2017-01-06
First Post:
2012-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Sponsor:
Amgen Research (Munich) GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MT103-208
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None